➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Medtronic
McKinsey
Harvard Business School
Colorcon

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

ENALAPRIL MALEATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Enalapril Maleate patents expire, and what generic alternatives are available?

Enalapril Maleate is a drug marketed by Apothecon, Beximco Pharms Usa, Heritage Pharma, Ivax Sub Teva Pharms, Krka Dd Novo Mesto, Mylan, Nostrum Labs Inc, Sandoz, Sandoz Inc, Sun Pharm Inds Ltd, Taro, Watson Labs, Wockhardt Ltd, Cosette, Dr Reddys Labs Ltd, Taro Pharm Inds, and Upsher Smith Labs. and is included in twenty-three NDAs.

The generic ingredient in ENALAPRIL MALEATE is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.

Drug patent expirations by year for ENALAPRIL MALEATE
Drug Prices for ENALAPRIL MALEATE

See drug prices for ENALAPRIL MALEATE

Drug Sales Revenue Trends for ENALAPRIL MALEATE

See drug sales revenues for ENALAPRIL MALEATE

Recent Clinical Trials for ENALAPRIL MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Manchester University NHS Foundation TrustPhase 2
Newcastle-upon-Tyne Hospitals NHS TrustPhase 3
University of DurhamPhase 3

See all ENALAPRIL MALEATE clinical trials

Pharmacology for ENALAPRIL MALEATE
Medical Subject Heading (MeSH) Categories for ENALAPRIL MALEATE
Paragraph IV (Patent) Challenges for ENALAPRIL MALEATE
Tradename Dosage Ingredient NDA Submissiondate
EPANED SOLUTION;ORAL enalapril maleate 208686 2018-08-31
EPANED KIT FOR SOLUTION;ORAL enalapril maleate 204308 2016-06-21
VASOTEC TABLET;ORAL enalapril maleate 018998

US Patents and Regulatory Information for ENALAPRIL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075556-001 Aug 22, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Nostrum Labs Inc ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075178-004 Mar 23, 2001 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075501-001 Aug 22, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Medtronic
McKinsey
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.